Difficulty: Medium
Average Score: 80%
Practice
Oral medications are often used as an early treatment for generalized spasticity. Which of the following works at the level of skeletal muscle to block calcium release from the sarcoplasmic reticulum?
Correct answer
A
Rationale
In the context of treating generalized spasticity, it is crucial to understand the mechanism of action of different medications to ensure effective management. In this case, the correct answer is A) dantrolene sodium. Dantrolene sodium works at the level of skeletal muscle by directly blocking calcium release from the sarcoplasmic reticulum. This action leads to muscle relaxation, making it an effective treatment for spasticity.
Now, let's analyze why the other options are incorrect:
- B) Clonidine acts centrally by stimulating alpha-2 adrenergic receptors in the brain and spinal cord, leading to reduced sympathetic outflow. While it may help with spasticity in some cases, it does not directly target skeletal muscle calcium release like dantrolene sodium.
- C) Tizanidine also acts centrally by stimulating alpha-2 adrenergic receptors to reduce spasticity through its effects on the spinal cord. It does not work at the level of skeletal muscle like dantrolene sodium.
- D) Baclofen acts as a GABA-B receptor agonist in the spinal cord, reducing excitatory neurotransmitter release. While effective for spasticity, it does not target calcium release from the sarcoplasmic reticulum in skeletal muscle.
Educationally, understanding the specific mechanisms of action of medications used in treating spasticity is essential for healthcare providers caring for pediatric patients. This knowledge helps in selecting the most appropriate treatment based on the underlying pathophysiology, leading to better outcomes for the child.
Now, let's analyze why the other options are incorrect:
- B) Clonidine acts centrally by stimulating alpha-2 adrenergic receptors in the brain and spinal cord, leading to reduced sympathetic outflow. While it may help with spasticity in some cases, it does not directly target skeletal muscle calcium release like dantrolene sodium.
- C) Tizanidine also acts centrally by stimulating alpha-2 adrenergic receptors to reduce spasticity through its effects on the spinal cord. It does not work at the level of skeletal muscle like dantrolene sodium.
- D) Baclofen acts as a GABA-B receptor agonist in the spinal cord, reducing excitatory neurotransmitter release. While effective for spasticity, it does not target calcium release from the sarcoplasmic reticulum in skeletal muscle.
Educationally, understanding the specific mechanisms of action of medications used in treating spasticity is essential for healthcare providers caring for pediatric patients. This knowledge helps in selecting the most appropriate treatment based on the underlying pathophysiology, leading to better outcomes for the child.